This program is located in a public school and, therefore, the program may not be responsible for correcting the violation.
Date |
Inspection Type |
Inspection ID |
Inspection Result |
|
Mar 26, 2025 |
Annual Unannounced |
2025-I-LIRO-001718
|
No violations cited for this Inspection |
|
Dec 18, 2024 |
Monitoring |
2024-I-LIRO-115384
|
No violations cited for this Inspection |
|
Sep 27, 2024 |
Monitoring |
2024-I-LIRO-099031
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
414.11(h)(5)(i) |
A written Individual Health Care Plan must be developed for the child; |
Corrected |
|
Jun 21, 2024 |
Annual Unannounced |
2024-I-LIRO-077301
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
414.11(f)(20) |
In the case of medication that needs to be given on an ongoing, long-term basis, the authorization and consent forms for children must be reauthorized at least once every 12 months. Any changes in the medication authorization related to dosage, time or frequency of administration shall require a program to obtain new instructions written by the licensed authorized prescriber. All other changes to the original medication authorization require a change in the prescription. |
Corrected |
414.11(h)(5) |
When a program has not been authorized to administer medications in a day care setting in accordance with the requirements of subdivision (f) of this section, a designated staff may administer emergency care through the use of patient-specific epinephrine auto-injectors, Diphenhydramine, when prescribed in combination with the auto-injector, asthma inhalers and asthma nebulizers when necessary to prevent anaphylaxis or breathing difficulty for an individual child, but only when the parent and the child's health care provider have indicated such treatment is appropriate. In addition: |
Corrected |
|
Aug 15, 2023 |
Application - Renewal |
2023-I-LIRO-024985
|
No violations cited for this Inspection |
|